Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.

The effects of acetylation on gene expression are complex, with changes in chromatin accessibility intermingled with direct effects on transcriptional regulators. For the nuclear receptors, both positive and negative effects of acetylation on specific gene transcription have been observed. We report that p300 and steroid receptor coactivator 1 interact transiently with the glucocorticoid receptor and that the acetyltransferase activity of p300 makes an important contribution to glucocorticoid receptor-mediated transcription. Treatment of cells with the deacetylase inhibitor, sodium butyrate, inhibited steroid-induced transcription and altered the transient association of glucocorticoid receptor with p300 and steroid receptor coactivator 1. Additionally, sustained sodium butyrate treatment induced the degradation of p300 through the 26S proteasome pathway. Treatment with the proteasome inhibitor MG132 restored both the level of p300 protein and the transcriptional response to steroid over 20 h of treatment. These results reveal new levels for the regulatory control of gene expression by acetylation and suggest feedback control on p300 activity.

[1]  D. DeFranco,et al.  Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking , 2002, Molecular and Cellular Biology.

[2]  Melissa A. Wilson,et al.  The Histone Deacetylase Inhibitor Trichostatin A Blocks Progesterone Receptor-mediated Transactivation of the Mouse Mammary Tumor Virus Promoter in Vivo * , 2002, The Journal of Biological Chemistry.

[3]  L. Sheldon,et al.  Steroid Hormone Receptor-mediated Histone Deacetylation and Transcription at the Mouse Mammary Tumor Virus Promoter* , 2001, The Journal of Biological Chemistry.

[4]  A. Caudy,et al.  Regulation of Transcriptional Activation Domain Function by Ubiquitin , 2001, Science.

[5]  Jianqi Yang,et al.  Sodium Butyrate Induces Transcription from the Gαi2Gene Promoter through Multiple Sp1 Sites in the Promoter and by Activating the MEK-ERK Signal Transduction Pathway* , 2001, The Journal of Biological Chemistry.

[6]  K. Yamamoto,et al.  Continuous recycling: a mechanism for modulatory signal transduction. , 2001, Trends in biochemical sciences.

[7]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[8]  L. Kedes,et al.  Proteasome-Mediated Degradation of the Coactivator p300 Impairs Cardiac Transcription , 2000, Molecular and Cellular Biology.

[9]  J. Peters,et al.  Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. , 2000, Genes & development.

[10]  R. Conaway,et al.  Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Gorbea,et al.  Regulation of the 26S proteasome by adenovirus E1A , 2000, The EMBO journal.

[12]  C. Pickart,et al.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Li Zhao,et al.  Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. O’Malley,et al.  The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation , 2000 .

[15]  M. Tyers,et al.  Transcriptional regulation: Kamikaze activators , 2000, Current Biology.

[16]  C. Lange,et al.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Gilman,et al.  Proteasome‐mediated degradation of transcriptional activators correlates with activation domain potency in vivo , 1999, The EMBO journal.

[18]  A. Burny,et al.  HIV‐1 Tat transcriptional activity is regulated by acetylation , 1999, The EMBO journal.

[19]  R. Klausner,et al.  Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Wolffe,et al.  p300 stimulates transcription instigated by ligand‐bound thyroid hormone receptor at a step subsequent to chromatin disruption , 1999, The EMBO journal.

[21]  R. Evans,et al.  Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.

[22]  B. O’Malley,et al.  Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Evans,et al.  A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity , 1999, Cell.

[24]  Aaron Ciechanover,et al.  The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.

[25]  V. Ogryzko,et al.  Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.

[26]  S. Nordeen,et al.  Steroid-selective Initiation of Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Is Controlled by the Site of Promoter Integration* , 1998, The Journal of Biological Chemistry.

[27]  C. Glass,et al.  Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.

[28]  A. Wolffe,et al.  Xenopus NF‐Y pre‐sets chromatin to potentiate p300 and acetylation‐responsive transcription from the Xenopus hsp70 promoter in vivo , 1998, The EMBO journal.

[29]  A. Goldberg,et al.  Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.

[30]  W. Zhang,et al.  Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. T. Kadonaga,et al.  p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. , 1998, Genes & development.

[32]  C. Glass,et al.  Transcription factor-specific requirements for coactivators and their acetyltransferase functions. , 1998, Science.

[33]  L. Kedes,et al.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.

[34]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[35]  Dirk Bohmann,et al.  Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases , 1997, Science.

[36]  Andrew J. Bannister,et al.  The TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity , 1996, Cell.

[37]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[38]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[39]  D. Livingston,et al.  The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Beato,et al.  Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Montminy,et al.  Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.

[42]  B. Howard,et al.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.

[43]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[44]  M. Beato,et al.  Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. , 1995, The EMBO journal.

[45]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[46]  K. Yamamoto,et al.  Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. , 1993, Science.

[47]  P. Yaciuk,et al.  Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth , 1993, Journal of virology.

[48]  G. Hager,et al.  Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Cato,et al.  Mineralocorticoid regulation of transcription of transfected mouse mammary tumor virus DNA in cultured kidney cells , 1988, The Journal of cell biology.

[50]  N. Defer,et al.  Selective inhibition by sodium butyrate of glucocorticoid-induced tyrosine aminotransferase synthesis in hepatoma tissue-cultured cells. , 1981, European journal of biochemistry.

[51]  R. Palmiter,et al.  Butyrate and related inhibitors of histone deacetylation block the induction of egg white genes by steroid hormones , 1980, Cell.

[52]  R. Reeves,et al.  Sodium butyrate inhibits histone deacetylation in cultured cells , 1978, Cell.

[53]  V. Ingram,et al.  n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells , 1977, Nature.

[54]  A. Wolffe,et al.  Thyroid hormone receptor, v-ErbA, and chromatin. , 2000, Vitamins and hormones.

[55]  B. O’Malley,et al.  FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent , 2000, Nature Cell Biology.

[56]  S. Nef,et al.  microRNAs in the testis: building up male fertility. , 2010, Journal of andrology.